CSIR in partnership with Laxai Sciences to seek regulatory approval to undertake clinical trials on Covid-19 patients Read more
73 per cent doctors cite ‘antiviral agents’ as most effective therapy for treating COVID-19: Course5 Intelligence report Read more
MTaI urges govt to release all consignments of medical devices to meet shortage of equipment for treatment of COVID-19 patients Read more
Capgemini as part of its global Social Response Unit activities extends support to Government of Maharashtra, BMC Read more
Wockhardt Hospital, Mumbai Central gets approval from DCGI to conduct convalescent plasma therapy trials Read more